Stop by Booth 609 and say hello!
Exhibit Hall Schedule
Sunday, April 27: 12:00 - 5:00 pm
Monday, April 28: 9:00 am - 5:00 pm
Tuesday, April 29: 9:00 am - 5:00 pm
Wednesday, April 30: 9:00 am - 12:00 pm
Click here if you'd like to schedule some time to meet with us at our booth!
I. Exhibitor Spotlight Theatre
Register to attend in person >
Refreshments will be provided, space is limited
I won't be able to attend in person but I am interested in receiving the recording of the talks >
CRISPR Screening, TCR / BCR sequencing, and other approaches for drug target and biomarker discovery
Spotlight Theatre D, Monday, April 28, 2025, 3:00-4:00 p.m.
McCormick Place Convention Center
Introductory Remarks: An overview of Cellecta technologies
Paul Diehl, PhD, COO, Cellecta
Speaker 1: Eugenio Morelli, MD, Assistant Professor, University of Torino. Group Leader, Laboratory for RNA Translational Research, Candiolo Cancer Institute, FPO-IRCCS
Title: Functional transcriptomics for isoform level dissection of lncRNA cancer dependencies
CRISPR-Cas13d screening reveals widespread lncRNA dependencies in tumors. Our IsoScan platform deciphers their isoform-specific functions, identifying key oncogenic drivers and exposing critical therapeutic vulnerabilities for precision oncology.
Speaker 2: Alex Chenchik, PhD, President & Chief Scientific Officer, Cellecta
Title: A practical guide for adaptive immune receptor repertoire profiling and the characterization of antigen-induced clonotypes with applications in vaccine development, autoimmunity, and cancer
T-cell receptor (TCR) and B-cell receptor (BCR) sequencing, also referred to as adaptive immune receptor (AIR) repertoire profiling, holds great potential for the understanding of disease mechanisms and the development of new treatments in infectious disease, autoimmunity, and immuno-oncology. This potential could be greatly improved by combining information about T- and B-cell receptor clonotypes with immunophenotypes of these cells. We will provide an overview of AIR profiling technology platforms, practical recommendations for selecting experimental samples, and best practices for generating and subsequently running bioinformatic analysis of the quantitative repertoire profiling data. We will discuss potential strategies for when to use bulk, cell fractions, and single-cell analysis for the discovery, validation, and immunophenotyping of antigen-activated clonotypes as well as some relevant applications in different disease areas, including cancer.
Register to attend in person >
Refreshments will be provided, space is limited
I won't be able to attend in person but I am interested in receiving the recording of the talks >
This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Spotlight Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the American Association for Cancer Research® (AACR).
II. Poster Presentations
POSTER BOARD #10: A comparative analysis of droplet-based and compartment-free sc-CRISPR-RNAseq platforms
Presented by Mikhail Makhanov, PhD, Research Scientist, Bioinformatics, Cellecta
Monday, April 28th from 2:00 - 5:00 pm
Poster Section 11
Abstract number: 2772
POSTER BOARD #23: Screens to identify TCR-specific epitopes using engineered antigen-presenting cells
Presented by Alex Chenchik, Ph.D., Cellecta President & CSO
Tuesday, April 29 from 2:00 - 5:00 pm
Poster Section 16
Abstract number: 5495
Click here if you'd like to schedule some time to meet with us at our booth!
